Edwards, JenaValve would control market, US FTC expert testifies
Edwards Lifesciences and JenaValve, if their merger is permitted, would control the entire market for transcatheter aortic valve replacement devices used to treat aortic regurgitation, an expert witness testified for the...To view the full article, register now.
Already a subscriber? Click here to view full article